Biosimilars... Not rituxan, but 'highly similar' to rituxan?
Biosimilar --- WHO definition.
'A biotherapeutic product which is similar in terms of quality, safety and efficacy to an already licensed reference biotherapeutic product.'
Dr. Sharman... raises some questions...
Be interesting to see the results of a poll on who would be interested in joining a trial for a Rituximab biosimilar...
Very true Neil... Frankly, I would rather have Samsung, make my TV than my rituxan biosimilar...
Only Apple makes my phones... but maybe they are brewing ibrutinib on Cupertino...who knows...follow the money!
Actually, Samsung has pulled out of the rituxan biosimilar race...but many companies remain... 7 billion annual market... tempting.
Start a Community